Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells

British Journal of Pharmacology
J TarasiukEdward Borowski

Abstract

1. Multidrug resistance (MDR) to antitumour agents, structurally dissimilar and having different intracellular targets, is the major problem in cancer therapy. MDR phenomenon is associated with the presence of membrane proteins which belong to the ATP-binding cassette family transporters responsible for the active drug efflux leading to the decreased intracellular accumulation. 2. The search of new compounds able to overcome MDR is of prime importance. 3. Recently we have synthesized a new family of anthrapyridone compounds. The series contained derivatives modified with appropriate hydrophobic or hydrophylic substituents at the side chain. 4. The interaction of these derivatives with erythroleukemia K562 sensitive and K562/DOX resistant (overexpressing P-glycoprotein) cell lines has been examined. The study was performed using a spectrofluorometric method which allows to continuously follow the uptake and efflux of fluorescent molecules by living cells. 5. It was demonstrated that the increase in the lipophilicity of anthrapyridones favoured the very fast cellular uptake exceeding the rate of P-gp dependent efflux out of the cell. For these derivatives, very high accumulation (the same for sensitive and resistant cells) was ob...Continue Reading

References

Mar 14, 1991·European Journal of Biochemistry·F Frezard, A Garnier-Suillerot
Sep 19, 1989·Biochimica Et Biophysica Acta·J TarasiukL Gattegno
Sep 15, 1987·Biochemical Pharmacology·W T Beck
May 1, 1995·Biological Chemistry Hoppe-Seyler·K PalfnerJ Bertram
Jun 1, 1995·Nature Medicine·G L SchefferR J Scheper
Sep 4, 1995·International Journal of Cancer. Journal International Du Cancer·L A DoyleD D Ross
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·G J ZamanH J Broxterman
Apr 21, 1993·Journal of the National Cancer Institute·P M Chaudhary, I B Roninson
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·S PaulG D Kruh
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U A Germann
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D W LoeS P Cole
Jun 23, 1999·Journal of Medicinal Chemistry·D BergerD Powell
Jul 25, 2000·Antisense & Nucleic Acid Drug Development·C Garcia-ChaumontJ Bolard
Feb 28, 2001·European Journal of Pharmacology·K Tkaczyk-GobisA Garnier-Suillerot

❮ Previous
Next ❯

Citations

Mar 5, 2013·European Journal of Medicinal Chemistry·Vicente Castro-CastilloBruce K Cassels
May 23, 2006·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·W-F FongH-Y Cheung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.